Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Equity Ratio (2019 - 2025)

Pulmonx (LUNG) has disclosed Equity Ratio for 7 consecutive years, with 0.47 as the latest value for Q2 2025.

  • On a quarterly basis, Equity Ratio fell 19.92% to 0.47 in Q2 2025 year-over-year; TTM through Jun 2025 was 0.47, a 19.92% decrease, with the full-year FY2024 number at 0.53, down 20.82% from a year prior.
  • Equity Ratio was 0.47 for Q2 2025 at Pulmonx, down from 0.53 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.85 in Q1 2021 to a low of 0.47 in Q2 2025.
  • A 5-year average of 0.69 and a median of 0.69 in 2023 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: fell 1.61% in 2022, then dropped 20.82% in 2024.
  • Pulmonx's Equity Ratio stood at 0.82 in 2021, then fell by 3.23% to 0.8 in 2022, then dropped by 16.31% to 0.67 in 2023, then dropped by 20.82% to 0.53 in 2024, then dropped by 10.92% to 0.47 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Equity Ratio are 0.47 (Q2 2025), 0.53 (Q4 2024), and 0.56 (Q3 2024).